Cardiovascular Diseases Clinical Trial
To identify and describe the distribution of risk factors for cardiovascular disease in a cohort of free-living elderly persons.
BACKGROUND:
Cardiovascular disease is the leading cause of mortality in older persons in the United
States. Nearly two-thirds of all deaths in men and women 65 years of age or older are due to
some manifestation of cardiovascular disease. Further, cardiovascular disease is a major
cause of disability in the elderly. Although there is relatively extensive epidemiologic
data on risk factors for cardiovascular disease in younger individuals, particularly younger
men, in 1986 when the study was initiated, relatively little information existed on the
prevalence and antecedents of cardiovascular disease in men and women over 65 years of age.
Further, the data that did exist tended to be contradictory. From a public health
perspective, it was important to identify risk factors for cardiovascular disease in older
individuals for several reasons. The numbers and proportion of elderly persons in the U.S.
were growing, and would continue to grow well into the next century. This segment of our
society, which comprised 12 percent of the population in 1986, accounted for one third of
our health care costs. Older Americans will continue to make significant demands on the
health care system in the coming decades. The identification of risk factors for this major
public health problem (e.g., cardiovascular disease) may lead to interventions which would
improve the health of older Americans and thus benefit the entire society.
Data for this project have been gathered since 1975 by the Dunedin Program, a
population-based geriatric health-screening program. This Program was designed to screen
persons 65 years of age or older for a wide variety of medical disorders. It was situated in
Dunedin, Florida, which is on the mid-west Gulf coast. Each participant was seen at the
clinic once a year. The clinic visit consisted of registration, a physical examination, and
questionnaire/medication form. Data were available on family history of illnesses, illnesses
of participant, smoking history, alcohol use, emotional status, coffee consumption, dietary
habits, current symptoms, social activities, exercise, attitudes towards health care,
height, weight, blood pressure, carotid artery auscultation, electrocardiogram, lipid
levels, blood chemistries and blood counts, diabetes, urine samples, and medication use. In
1986, a total of 5,085 persons had completed the first screening examination and 1,540 had
completed a full eight years of screening.
DESIGN NARRATIVE:
In the first phase, follow-up time for each participant was computed and changes in risk
factor status analyzed. Cardiovascular disease incidence and mortality rates were
calculated. In the second phase, incidence rates of cardiovascular disease were computed by
category of risk factor level at baseline. The relative risk of cardiovascular disease was
calculated for each risk factor. Multivariable analyses were carried out in the third phase.
Regression models were used to determine independent and interactive effects of the
identified risk factors on the incidence of and mortality from cardiovascular disease.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|